Intratumoral Holmium-166 Microsphere Injection in Patients with Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Center, Single-Arm, Open-Label Feasibility and Safety Study
Intratumoral injection of holmium-166 microspheres in patients with unresectable PDAC seems feasible and safe. Research into minimally invasive image-guided application is advised.
Authors
- John J. Hermans (ORCID: https://orcid.org/0000-0001-9207-0548)
- Harm Westdorp (ORCID: https://orcid.org/0000-0002-3336-4164)
- Jurgen J. Fütterer (ORCID: https://orcid.org/0000-0001-6800-2879)
- Martijn W.J. Stommel (ORCID: https://orcid.org/0000-0002-4257-5254)
- J. Frank W. Nijsen (ORCID: https://orcid.org/0000-0001-7625-2253)
- Sjoerd F.M. Jenniskens (ORCID: https://orcid.org/0000-0003-3237-5838)
- Coen Ysbrand Willink (ORCID: https://orcid.org/0000-0001-6531-0358)
- Marcel J. R. Janssen (ORCID: https://orcid.org/0000-0002-2567-7734)
- Cornelis J. H. M. van Laarhoven
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
Publication Details
- Journal
- Digestive Surgery
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1159/000545246
- Citations
- 2
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09